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ABSTRACT: 
 
Background: Worksite screening programs are increasingly being provided by 
employers as a means to reduce cardiovascular risk in employees.  A screening 
program that consists of fasting serum analysis of glucose plus a lipid panel is 
offered yearly to employees at the VA medical center in Tampa. A retrospective 
study was conducted to determine if a wellness clinic exposure resulted in 
significant changes in employees’ markers of cardiovascular risk. 
 
Methods:  Computerized records were used to follow serial outcomes for 
glucose, triglycerides, HDL cholesterol, and LDL cholesterol in employees whose 
screening results showed abnormal levels of one or more of these markers.  An 
intervention group with 66 subjects received a wellness clinic visit including a 
health risk assessment and education for lifestyle change, and a reference group 
with 109 subjects received only serum analysis.  Outcomes at repeat screening 
were compared for the two groups. 
 
Results:  Both groups showed improvement in cardiovascular risk.  In the 
intervention group there was significant intra-subject improvement from baseline 
for all markers except glucose.  For triglycerides and LDL cholesterol there was a 
significantly greater proportion of subjects who improved in the intervention 
group.  In addition, the improvement for triglycerides was significantly better in 
the intervention group. 
 vii 
 
 
Conclusions:  This investigation confirms the value of a worksite wellness 
program in reducing cardiovascular risk in the population studied.  A differential 
impact of age and gender was seen for glucose and triglycerides and indicates 
that such modifiers should be considered through covariate analysis in assessing 
wellness program effectiveness.  Increasing levels of employee wellness 
participation to targets identified in this study and adding a health risk 
assessment for everyone screened will help to identify the specific benefits of the 
face to face wellness counseling intervention. 
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I.  INTRODUCTION  
 
Rationale, Scope, and Prevalence of Worksite Health Promotion 
Worksites are an important setting for preventive health education because of the 
potential to reach a large audience, estimated at 130 million American workers.  
In addition to improving employee quality of life through interventions that help 
prevent illness, workplace health promotion can improve employee satisfaction 
due to the perceived investment by employers in workers’ health, especially 
when programs emphasize stress reduction.  Greater employee satisfaction can 
lead to improved morale, lower turnover, and improved productivity.   
 
Workplace health promotion programs may take place at onsite employee health 
clinics, particularly when the worksite is a medical center.  Many worksites, 
however, do not have onsite employee clinics.  These organizations use methods 
such as mobile van units or clinics outside the corporate facilities to provide 
preventive medical services for their employees.   Venues such as conference 
and dining areas provide additional space for large groups in both cases.  For 
non-medical organizations, the screenings are usually conducted by outside 
medical personnel or trained in-house volunteers, while in medical centers, these 
services are performed by on-site medical staff. 
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Increasingly, preventive care programs given onsite at the workplace are known 
as worksite wellness programs.  Use of the term ‘wellness’ in industrial and 
corporate settings arose during the 1970’s when a shift occurred in national 
health policy.  This shift emphasized improving health and maintaining good 
health through lifestyle practices such as regular exercise, good nutrition, and 
smoking cessation, rather than a purely biomedical approach emphasizing the 
diagnosis and treatment of illness (Lovato, Green, & & Stainbrook, 1994) as cited 
in (Association for Worksite Health Promotion, 1994).  The term ‘wellness’ 
provided an attractive label for advertising workplace preventive programs as it 
signified the opposite of ‘illness’. 
 
The wellness concept also implied, from its inception, employer investment not 
only in physical health of workers but also in psychosocial health, which 
suggested the need to include diverse approaches to individual wellbeing.  
Worksite health promotion or wellness programs thus provide a broad range of 
interventions across work settings.  In 1988, the most frequently cited health 
promotion activities in a survey of worksites were smoking control, health risk or 
health status assessment, back care, stress management, exercise and fitness, 
and off-the-job accident prevention (Christenson & Kiefhaber, 1988).  Some less 
typical suggestions for programming include parenting tips and preventive 
dentistry (Partnership for Prevention, 2010).  The US Department of Health and 
Human Services outlined 5 components of a comprehensive worksite health 
promotion program in Healthy People 2010, shown in Table 1 (Linnan et al., 
2008).   
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Table 1:  Components of a comprehensive worksite health promotion program 
 
Component 1 
 
Health Education: Establishes desired target levels in the following areas:  physical 
activity, nutrition with cholesterol education, weight management or counseling, 
smoking cessation classes or counseling, blood pressure classes or counseling, 
alcohol or drug abuse support, workplace injury prevention, workplace violence 
prevention, maternal or prenatal programs, HIV or AIDS education, cancer 
prevention.  Other areas in development are:  Diabetes prevention, recognition of 
early warning signs of acute MI, recognition of early warning signs of stroke. 
Component 2 
 
Supportive social and physical environment:  Addresses establishing workplace 
policies that promote health, such as: formal tobacco policy that prohibits smoking or 
limits it to separately ventilated areas, nutrition or weight management classes, 
employer-sponsored physical activity such as walking trails or on-site fitness facilities, 
encouragement of health insurance acquisition. 
Component 3   
 
Integration in organizational structure:  Management or owner support of health 
promotion should exist, with health promotion as part of a strategic plan, as evidenced 
by having staff, an office and a budget dedicated to such programs. 
Component 4 
 
Linkage to other employee services:  Refers to benefit from partnerships between 
worksite health promotion and other workplace programs. These include but are not 
limited to: Employee Assistance Programs, Occupational Medicine programs for 
medical surveillance, Human Resources Programs for performance planning and 
development, and Disability Management Programs. 
Component 5 
 
Screening programs:  Establishes target numbers of adults screened for high blood 
pressure and elevated cholesterol. 
 
The worksite health programs offered most frequently in a more recent national 
study of worksite health promotion were found to be employee assistance and 
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back injury prevention programs (Linnan et al., 2008).  These interventions, along 
with blood pressure and blood cholesterol screening, were offered more 
frequently with increasing size of the workplace (measured by number of 
employees).  Overall, the authors found that less than 10% of responding 
employers offered all 5 elements of a comprehensive worksite health promotion 
program, which sharply contrasts with the Healthy People 2010 objective of 75% 
of worksites.  The element most frequently incorporated was linkage to related 
programs.  Worksite screening was the least frequently incorporated except in 
the largest size category of 750 employees or more.  In this category a 
supportive social and physical environment was the component from Table 1 
least often encountered.  
 
Cardiovascular Disease Prevention in Workers 
In regard to the link between employment and cardiovascular disease, Bosma, et 
al. showed a positive association between work stressors and elevated risk of 
cardiovascular disease (Bosma, Stansfeld, & Marmot, 1998).  Calvert et al. 
compared occupation-specific rates of ischemic heart disease and found higher 
mortality from ischemic heart disease in certain categories of workers that 
included sheriffs, firefighters, and machine operators (Calvert, Merling, & Burnett, 
1999).  They suggested their results could be used as a starting point to target 
cardiovascular disease prevention programs to those occupations where such 
programs would be most beneficial. 
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Programs emphasizing cardiovascular disease prevention in the worksite setting 
have increased steadily.  Several reasons explain this increasing emphasis on 
cardiovascular disease prevention in worksite health promotion.  1) Since the 
second half of the 1970’s, prevention of cardiovascular disease through smoking 
cessation education and other lifestyle changes has been an important aspect of 
public health generally (Lovato et al., 1994) as cited in (Association for Worksite 
Health Promotion, 1994); 2) The influence of lifestyle on cardiovascular risk 
status means prevention is achievable through education; 3) Cardiovascular 
disease treatment is costly to insurers, and highly prevalent, thus prevention is of 
key importance to reduce employer insurance costs (Menzin, Wygant, Hauch, 
Jackel, & Friedman, 2008) and 4) As previously mentioned increasing numbers 
of working Americans provide worksite health educators with a potentially large 
audience, at any given session, toward whom to target health messages.  This 
increases the efficiency of delivery of disease prevention education and thus 
enhances its potential to reduce risk and costs to insurers. 
 
Numerous studies have evaluated the effects of specific worksite interventions 
on cardiovascular health risks.   A selection of such studies is given in Table 2.  
Of note, MOVE! is a health promotion program for veterans.  While veterans 
include retired persons and are therefore not a typical occupational group, the 
MOVE! program is nonetheless included in the present sample of studies 
because it has a high profile in the VA system. This could produce spill-over 
effects such that healthy behaviors would be expected in the VA employees who 
are the subject of the investigation detailed in this manuscript.   
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The studies reviewed in the table are primarily cardiovascular screening 
programs that were conducted for primary and secondary prevention at worksites 
across different industry types.  They all used risk factor questionnaires and 
recorded metrics before and after health promotion interventions.  Interventions 
included health education on multiple topics, blood pressure screening, healthy 
cafeteria food choices, weight loss, cholesterol reduction through diet and 
exercise counseling, and diabetes prevention.  The programs’ duration was from 
5 months (for MOVE!) to 2 years.  In addition to veterans, employees from 
industrial blue collar, technology sector, medical device manufacturing, and 
‘multiple employer’ services were represented. 
 
Outcome measures used in these studies included number of disability days per 
employee, weight, body mass index, blood pressure, smoking status, and blood 
levels of fasting blood glucose, triglycerides, high density lipoprotein (HDL) 
cholesterol and low density lipoprotein (LDL) cholesterol.  Aerobic fitness, waist 
circumference, oral glucose tolerance testing, and fasting insulin were some 
infrequently used outcome measure
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Table 2: Cardiovascular disease interventions in occupational health settings (plus veterans) 
Reference & industry Intervention  Results  Control 
Group 
Y/N 
 Cost 
Impact   
(Bertera, 1990) ‘blue-collar 
workers at an industrial 
company’ 
Health education: Pretest-
posttest design, multi-faceted 
health promotion at 41 
intervention/19 non intervention 
sites 
Reduced disability days 
among blue collar 
employees; good return 
on investment  (ROI) 
Y Y = $2 for 
each $1 
invested, 
200% yield 
(Karlehagen & Ohlson, 
2003) ‘technology based 
service enterprise ’ 
Diet and exercise counseling to 
reduce cholesterol 
 
5% reduction in total 
cholesterol vs. no change  
 
Y Not 
assessed   
(Aldana et al., 2006) 
‘medical device 
manufacturer’ 
Diabetes prevention (Diet ed, 
behavior change education in 
weekly sessions, onsite daily 
exercise classes, pedometer) 
Improvement in glucose 
tolerance testing and lipids 
after 6 months.  1/3 of 
subjects had normal 
glucose after 2 years. 
N Not 
assessed 
(Loeppke, Edington, & Beg, 
2010) multiple employer 
groups’ 
Customized personal prevention 
plan including one-on-one 
registered nurse coaching, 8 
week nutrition action program 
and personal account on 
Prevention Plan website; 
progress score linked to rewards. 
Aggregate health 
transitions: Increased 
percentage of the study 
group were in ‘Low –Risk’ 
category and decreased 
percentage in ‘Moderate-‘ 
and ‘High-Risk’ categories 
after 1 year.  
N Not 
assessed 
(Bachman A.C., 2011) 
MOVE 2009’ data at Bay 
Pines and Fort Myers VA 
medical centers  
 
Individualized treatment plan for 
weight control devised by Multi-
disciplinary team including 
physician, nutritionist, physical 
therapist and psychologist; 
monthly monitoring and finite 
graduation date 
5% - 10% weight loss 
within 3 months 
N Not 
assessed 
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Although many individual programs report efficacy of interventions in improving 
employees’ cardiovascular risk in the short term, it is not yet known how this 
translates into improved worker health in the long term. 
 
Study on Employee Lipid Screening and Wellness at the James A. Haley VA 
Medical Center 
Background:  Employees at VA Medical Centers, because they are concerned 
with providing inpatient and outpatient medical care to veterans, are exposed to 
health awareness education as part of the treatments provided.  This education 
includes the use of lifestyle measures such as good nutrition, exercise, weight 
control, and smoking cessation to prevent chronic disease.  These employees 
constitute a large group of federal workers which has the potential to promote 
health education messages from within the workplace to their families and 
communities.  Health promotion among employees of VA Medical Centers 
therefore presents a unique and rich opportunity to practice cardiovascular 
disease prevention.  
Each year employees at the James A. Haley (JAHVA) Medical center are offered 
fasting blood glucose and lipid screening as part of the facility’s wellness worksite 
health promotion program.  Wellness clinic visits conducted at the Occupational 
Health Clinic (OHC) by residents in preventive medicine are offered to counsel 
employees whose screening results are abnormally elevated.  These visits 
provide dietary and weight loss advice and counsel employees to incorporate 
therapeutic lifestyle changes that can prevent future illness and improve their 
quality of life.  
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Research question:  This study looked at the results of blood glucose and lipid 
screening in employees at a VA medical center to assess whether a wellness 
clinic visit improved cardiovascular risk.   All employees included in the study had 
abnormal glucose and lipid values at baseline; thus this was a secondary 
prevention intervention.  The primary research question was:  Does face-to-face 
education provided by a Preventive/Occupational Medicine resident at a 
scheduled wellness clinic visit improve serum cardiovascular risk biomarkers 
assessed on repeated screening at one year?   The wellness clinic visit was an 
intervention to improve cholesterol through diet and exercise counseling 
conducted by a physician taking part in the preventive and occupational medicine 
residency training program.  To our knowledge there are no other studies of a 
worksite health promotion intervention conducted by resident physicians or of 
secondary cardiovascular disease prevention in employees of a VA medical 
center.   
Study protocol outline:  A flow diagram of the study is provided in Figure 1. The 
study compared follow-up lab screening values between two groups – an 
exposed group consisting of those with abnormal screening values that received 
a wellness clinic visit, and an unexposed group consisting of those with abnormal 
screening values that declined a wellness clinic visit.  Except for glucose, 
abnormal values were defined using the cut-off ranges used by the JAHVA lab.  
Although Figure 1 shows repeat lab values from the consecutive years 2009 to 
2010, the study used all abnormal screening lab values obtained in 2007 to 2010 
as a baseline if screening was repeated after at least 6 months.  
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Labs 2009 out of range 
Wellness clinic visit = 
Exposure 
 Labs repeated 2010 
   
 Labs repeated 2010 
Exposed group: % 
decreased risk  
Unexposed group: % 
decreased risk 
Yes = Exposed No = Unexposed 
Figure 1. Protocol to compare follow-up biomarker values in 2 groups 
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II. METHODS 
 
Health Promotion at the James A. Haley VAMC 
 
Health promotion activities at the James A. Haley VA Medical Center include 
gym facilities for employees, employee MOVE!  Program, smoking cessation 
classes, yoga classes, newsletter, communication bulletin board on wellness 
topics in the clinic waiting area, a website with calendar of wellness events such 
as yoga classes, and screening programs (blood pressure, blood glucose and 
lipids).   
 
Annual employee blood glucose and lipid screening is scheduled over a period of 
several weeks, usually in February or March of each year.  Blood is drawn 
between 7am – 9am on designated days by lab employees at the screening site, 
which is a conference room or dining room temporarily allocated for this purpose.  
Employees log on to the employee Wellness website to receive information 
including directions to the location, and are instructed to fast for 12 hours prior to 
testing.  Employees wishing to participate print a consent form indicating 
willingness to be contacted to receive abnormal results.  Alternatively employees 
may pick up a paper copy of the results themselves from the Occupational Health 
Clinic.
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The wellness coordinator for the medical center oversees the wellness programs 
listed above.  The residents in preventive and occupational medicine conduct the 
wellness clinic visits for employees with abnormal lipid screening results.  These 
visits take place on-site at the medical center’s occupational health clinic. 
 
The Resident-conducted Wellness Clinic  
The primary aim of the JAHVA wellness clinic is to improve employees’ 
cardiovascular risk ratings by non-pharmacological means –such as using 
exercise to raise HDL cholesterol levels.  This emphasis on enhancing 
cardiovascular health through lifestyle changes is seen as important due to its 
ability to lower costs, prolong life, and improve quality of life for employees 
(Association for Worksite Health Promotion, 1994; Carnethon et al., 2009). 
The program has the potential to make a significant impact due to the large and 
relatively stable workforce.  Size is important because increased size of a 
workforce population exposed to health promotion not only creates a multiplier 
effect in the workplace but also increases the likelihood of spreading healthy 
lifestyle changes to the community.  Workforce stability is important because it 
creates a long time horizon to establish and maintain preventive health habits.  
Such habits are particularly critical in a population that is aging and approaching 
retirement since this is the life stage when health costs are highest. 
 
The first step during a typical wellness clinic visit is to obtain employees’ answers 
to a health risk assessment tool in the form of a detailed questionnaire that 
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includes family history and smoking status.  Health risk assessments are 
administered by worksite health promotion programs as an essential initial step in 
raising employee awareness and identifying individual employees’ baseline risk 
factors.  Sample health risk assessments for two wellness programs include the 
following 14 measures (Loeppke et al., 2010; VA Public Health Service, 2011):  
 
1. Self-rating of health 
2. Blood pressure by history or on-site measurement 
3. Weight or Body Mass Index 
4. Physical activity 
5. Medical Illness history 
6. Blood glucose by history or on-site measurement 
7. Cholesterol and lipids by history or on-site measurement 
8. Smoking status 
9. Use of relaxation medication or sleep aids 
10. Dietary habits such as fat consumption or lack of fiber 
11. Alcohol use 
12. Seat belt use 
13. Stress/life satisfaction 
14. Level of absenteeism 
 
 
Programs vary as to the inclusion of the above health measures, or additional 
ones not present on this list such as miles travelled by automobile each year.   
 
The wellness clinic visit at JAHVA conducted by residents includes the above 15 
measures and also asks about family history of cardiac disease in order to obtain 
the necessary parameters for the National Cholesterol Education Program – 
Adult Treatment Panel III (NCEP – ATP III) algorithm to determine optimum LDL 
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level (Expert Panel on Detection, Evaluation, and Treatment of High Blood 
Cholesterol in Adults, 2001). 
 
Subsequently, blood pressure, BMI and abdominal circumference are measured 
and a focused cardiovascular physical exam is performed which includes 
searching for signs of atherosclerosis (e.g. carotid bruits and abdominal 
aneurysms).  Screening lab values are reviewed and used along with other 
parameters to assess cardiovascular risk level.  Three formal cardiovascular risk 
methods are used:   
1. The Framingham calculator (National Cholesterol Education Program, 
2011) 
2. The NCEP – ATP III algorithm for determining target LDL level (Expert 
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol 
in Adults, 2001) 
3. Assessment for the 5 metabolic syndrome indicators (Expert Panel on 
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 
2001) 
 
These methods are shown in detail in the Appendix. 
 
Finally, the residents counsel the employees on non-medical therapy, tailoring 
their advice to the individual based on the elements discussed above.  The 
employee receives a written recommendation in the form of a Wellness 
‘prescription’.  Recommendations include mutually agreed upon goals such as 
targets for exercise frequency, weight loss, or cholesterol level achievable 
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through diet.  Suggestions are made for improving motivation for the behaviors 
necessary to achieve the goals, such as walking with a partner or using a 
pedometer to improve exercise motivation.  An example of a Wellness 
Prescription is given in the Figure A4. 
 
Data Overview 
Study Parameters:  Of the screening measures discussed above, those specific 
for increased risk of cardiovascular disease are obesity, defined as body mass 
index > 30 (National Heart Lung and Blood Institute - NIH, 2011) smoking, high 
blood pressure, diabetes or elevated fasting serum glucose, elevated fasting 
serum triglycerides, elevated fasting serum LDL cholesterol, and low HDL 
cholesterol.   
 
Risk ratings are performed as part of all wellness visits (as described above).  
The results of these ratings are included as a score in the electronic record 
documenting the clinic visit.  These risk assessments require parameters besides 
serum markers such as height, weight, abdominal circumference, blood 
pressure, and family history that can only be obtained during a medical clinic 
visit.  Therefore, these assessments are not performed on the employees who 
are screened for serum markers then subsequently decline a wellness clinic 
consultation.   
 
The availability of serial serum biomarker screening data in computerized health 
records presented an opportunity to review data retrospectively and compare 
 16 
 
follow-up results in patients who received individual counseling versus those who 
did not.   For the purpose of having a control group of subjects for comparison, 
only serum markers could be used because, as afore-mentioned, clinical data is 
collected at the time of the wellness visit and could not, therefore, be available for 
those who declined a wellness clinic consultation.  Consequently, this 
retrospective chart-based study used fasting levels of blood glucose and a 
fasting lipid panel as risk predictors of cardiovascular disease, and evaluated 
those with abnormalities in blood glucose, triglycerides, high-density lipoprotein 
(HDL) cholesterol and low-density lipoprotein (LDL) cholesterol.  The abnormal 
values for the four parameters were glucose > 99mg/dL, triglycerides > 149 
mg/dL, HDL cholesterol < 40 mg/dL, and LDL > 119 mg/dL.   For the lipid panel, 
these values correspond to the cut-offs used by the JAHVA lab.  For glucose, the 
lab cut-off is 110mg/dL for pre-diabetes.  However, it was decided to use the 
lower cut-off value of 100mg/dL which is increasingly used internationally to 
define both pre-diabetes and the related metabolic syndrome, both of which are 
known risk factors for cardiovascular disease (American Diabetes Association, 
2011; Meigs, Holman, Wolfsdorf, & Mulder, 2010). 
 
Data abstraction: The data to be analyzed were selected by starting with results 
returned from the lab during the annual screening period in 2010. The year 2010 
was the ‘index’ year reviewed as that coincided with the author’s residency 
training rotations in the JAHVA occupational health clinic; this was the study site 
where paper copy lab results were available for review.  If an abnormal result 
was returned, the subject was logged as a study subject.  Further chart review in 
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the electronic records data base was performed to determine if previous labs 
were also abnormal, if repeat screening was done, and if a wellness clinic 
consultation had occurred.  The inclusion criteria were thus:  an initial abnormal 
lab value, a repeat sample obtained for the same individual more than 6 months 
after the initial sample, and, for inclusion in the exposed group, an intervening 
wellness clinic consultation that occurred in the time frame between the two 
screening results.  Subjects were removed from the study log if data did not meet 
the criteria above.  Not all subjects underwent screening in the consecutive years 
2009-2010, however.  In order to maximize the sample size it was therefore 
necessary to include data from other baseline years according to the inclusion 
criteria above, based on reviewing these years’ data in the electronic records 
data-base.  The final study sample consisted of 109 unexposed subjects and 66 
that were exposed to a wellness clinic visit.  The yearly breakdown of screening 
results is as shown in Table 3.  As illustrated, the majority of repeat 
measurement pairs occurred in 2009-2010 followed by 2010-2011. 
 
Table 3:  Years in which screening measurements occurred 
Screening years 
(baseline – repeat) 
 
2007-08 
 
2008-09 
 
2009-10 
 
2010-11 
Number of subjects 
(Total n =175) 
22 29 81 43 
 
Data Analysis: Descriptive results are given 1) as distributions of biomarker value 
or proportional change frequencies and 2) as mean biomarker levels for baseline 
and repeat screening for the four biomarkers. 
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Bivariate data are of three types in this study: 1) the proportion of each group 
with improvement on repeat screening (shown graphically for the four markers 
using a side by side comparison of the two groups, 2) the intra-subject change 
from baseline measured at repeat screening, and 3) the difference in mean 
change (from baseline to repeat screening) between the unexposed and exposed 
groups. 
 
P-values for proportional change differences between the groups were obtained 
using the formula for the binomial approximation to the normal distribution.  P-
values for intra-subject change were obtained using the paired samples t-test.  
For comparisons between groups the independent samples t-test was used.  All 
tests of hypothesis for bivariate data were one-tailed (given that improvement 
was expected at the later screening in both groups) with a type I error rate fixed 
at 5%. 
 
Bivariate comparisons could not compensate for differences between the 
unexposed and exposed groups while adjusting for baseline characteristics 
which potentially masked or increased an effect of the wellness clinic visit.  
These potential confounders included age, gender and the degree of risk as 
indicated by the level of initial biomarker abnormality. Multivariate testing using 
analysis of covariance (ANCOVA) was performed in order to correct for the 
differences in age and gender between the two groups.  The General Linear 
Models procedure in SAS, Statistical Analysis Software (SAS Institute, 2008) was 
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used to conduct the analysis.  Hypothesis testing for covariate analysis used the 
confidence intervals around adjusted means that were obtained from the models. 
This study was approved by the Institutional Review Board at the University of 
South Florida. 
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III. RESULTS 
 
For 2010, the core year analyzed, screening results were returned by the lab for 
a total of 355 subjects.  Of these, 178 were considered abnormal by the criteria 
above, indicating cardiovascular risk, and 132 were normal.  The remaining 45 
were abnormal states without increased cardiovascular risk, such as HDL > 
100mg/dL. 
 
Descriptive Statistics for the Unexposed and Exposed Groups 
Figures A5 – A8 in the Appendix give the distributions of the respective samples 
for age and gender.  Table 4 shows the age and gender of the unexposed and 
exposed groups. 
 
Table 4:  Demographic data for unexposed and exposed groups 
 
Unexposed group 
N=109 
Exposed group 
N=66 
p-value 
 
Male gender 61 (56 %) 52 (79%) 0.0038 
Age  
     N 
     Mean (sd) 
     Median 
     Min-Max 
 
109 
50.53 (8.89) 
52 
25-68 
 
66 
48.36 (10.04) 
49 
24-68 
 
 
0.1383 
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The lipid screening service was used by a predominance of individuals older than 
45 in both groups, and a majority of the subjects in both groups were male.  Age 
variability was higher for the exposed group than the unexposed group, which 
also had proportionally more males (79% compared with 56% for the unexposed 
group). 
Proportion of exposed group with decreased, unchanged, or increased 
cardiovascular risk biomarker level, compared with unexposed group:  
Figures 2 - 5 show the outcomes of repeated samples in each group for each of 
the four biomarkers: glucose, triglycerides, HDL cholesterol and LDL cholesterol.  
Comparing change by proportions across the two groups showed an 
improvement in cardiovascular risk indicators both with and without exposure to a 
wellness clinic visit. 
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Figure 2  Comparison of repeat results for glucose in exposed and unexposed 
group, p =0.8629 
           
 
           
 
Figure 3  Comparison of repeat results for triglycerides in exposed and 
unexposed group, p = 0.0004 
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Figure 4  Comparison of repeat results for HDL cholesterol in exposed and 
unexposed group, p=0.2903 
 
            
 
Figure 5  Comparison of repeat results for LDL cholesterol in exposed and 
unexposed group, p=0.0062 
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For 3 out of the 4 biomarkers analyzed:  triglycerides, HDL and LDL cholesterol, 
a greater proportion of the exposed population than the unexposed population 
improved on repeat sampling.  With regard to glucose, a greater proportion of the 
group that received a wellness clinic visit had glucose values that increased - 
indicating higher risk - on repeat sampling.     
Direction of change in the exposed and unexposed groups:   Serum biomarker 
levels were improved on repeat screening for both groups.  That is, both exposed 
and unexposed groups showed a mean decrease in serum levels for glucose, 
triglycerides and LDL cholesterol, and a mean increase for HDL cholesterol. 
(Table 5). 
 
Hypothesis Testing Results 
For the proportional change outcomes illustrated above, the result was significant 
for two biomarkers, triglycerides and LDL cholesterol (Figures 2-5).  The intra-
subject change, i.e. the difference between baseline values and values on repeat 
measurements, was significant for triglycerides, HDL cholesterol, and LDL 
cholesterol and was non-significant for glucose (Table A1, in Appendix). 
Table 5 provides significance levels for comparisons between the groups. The 
difference in the observed improvement between the intervention and reference 
groups was significant only for triglycerides.   
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Table 5:  Mean difference between the unexposed and exposed groups 
 
Analysis of covariance was done to adjust the two groups for comparison given 
their differences in gender and age (Table 6).
  Unexposed 
Group 
Exposed Group p-value  
Glucose     
 N 59 20 0.0661 
 Mean (sd) -1.63(23.942) -19.75 (49.917)  
 Median -4 -5.5  
 Min, Max -81,113 -168,13.0  
Triglycerides*     
 N 45 33 0.0359 
 Mean (sd) -5.04 (91.497) -44.45 (97.785)  
 Median -2 -40  
 Min, Max -238,267 -287,198  
HDL 
Cholesterol 
    
 N 27 20 0.4085 
 Mean (sd) 3.11 (5.508) 2.75 (4.898)  
 Median 3 1.5  
 Min, Max -9,14.0 -7,11.0  
LDL 
Cholesterol 
    
 N 78 50 0.0595 
 Mean (sd) -9.4 (22.258) -17.6 (32.272)  
 Median -3.5 -8.5  
 Min, Max -73,39.0 -115,58.0  
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Table 6:  Adjusted means after analysis of covariance 
 
Adjusted means after analysis of covariance by gender Unadjusted Mean Differences 
 Unexposed Mean (95% CI) Exposed Mean  (95% CI) Unexposed Mean Exposed Mean 
Glucose -1.29 (-10.02 to 7.45) -19.16 (-34.17 to -4.15) -1.63 -19.75 
Triglycerides -0.53 (-29.27 to 28.22) -33.56 (-70.30 to 3.18) -5.04 -44.45 
HDL cholesterol 4.82 (1.90 to 7.75) 4.73 ( 1.34 to 8.12) 3.11 2.75 
LDL cholesterol -9.57 (-15.58 to -3.56) -18.30 (-26.13 to -10.47) -9.4 -17.6 
Adjusted means after analysis of covariance by age 
  
 Unexposed Mean (95% CI) Exposed Mean  (95% CI) Unexposed Mean Exposed Mean 
Glucose -1.62 ( -9.96 to 6.72) -19.77(-34.10 to -5.45) -1.63 -19.75 
Triglycerides -5.14 (-33.40 to 23.13) -44.33 (-77.38 to -11.28) -5.04 -44.45 
HDL cholesterol 3.08 (1.11 to 5.05) 2.79 (0.50 to 5.08) 3.11 2.75 
LDL cholesterol -9.39 (-15.37 to -3.40) -17.60 (-25.07 to -10.12) -9.4 -17.6 
Adjusted means after analysis of covariance by age and gender 
  
 Unexposed Mean (95% CI) Exposed Mean  (95% CI) Unexposed Mean Exposed Mean 
Glucose -1.05 (-9.73 to 7.63) -18.78(-33.70 to -3.86) -1.63 -19.75 
Triglycerides 0.12 (-29.17 to 29.41) -33.36 (-70.36 to 3.64) -5.04 -44.45 
HDL cholesterol 4.60 (1.75 to 7.45) 4.55 (1.25 to 7.84) 3.11 2.75 
LDL cholesterol -9.58 (-15.62 to -3.54) -18.35 (-26.26 to -10.44) -9.4 -17.6 
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Adjustment with analysis of covariance for gender produced significant mean 
differences between the groups for glucose.  Adjusting for age showed significant 
inter-group differences for both glucose and triglycerides.  Significance here is 
defined as a confidence interval not containing zero in the exposed group while 
the confidence interval contains zero in the unexposed.  Analysis of covariance 
for age and gender combined showed a significant difference between the 
groups for glucose only.  These findings and their implications are discussed in 
the next section. 
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IV. DISCUSSION 
 
Significance of Findings 
This study included only wellness program participants whose screening results 
were abnormal and who sought effects of lifestyle changes in improving these 
parameters.  Interestingly, more than half (or 178 of 355) of subjects screened in 
2010 had abnormally elevated serum biomarkers for cardiovascular disease.  
This implies that half or more of those seeking screening have an actual need for 
secondary prevention, as opposed to being the ‘worried well’ (Lynch, Gilfillan, 
Jennett, & McGloin, 1993).  Although these annual data were not obtained for 
other years, it would be useful to do so in similar studies undertaken in the future 
in order to determine the trends in prevalence of abnormal screening parameters 
in this worksite population.   
 
The study result showing improvement in both groups has several possible 
explanations.  The improvement in the controls as well as intervention groups 
could have been due to a beneficial effect of screening at baseline.  This 
explanation, a type of screening bias, has been suggested for similar results 
observed in other cardiovascular disease prevention studies such as the Multiple 
Risk Factor Intervention Trial also known as MR FIT and a more recent worksite 
health promotion study by Racette et al (Kjelsberg, Cutler, & Dolecek, 1997; 
Racette et al., 2009).  This constitutes volunteer bias.  The fact that both 
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intervention and control groups of the study underwent blood glucose and lipid 
screening indicates that both were likely motivated to pursue good health, with or 
without a wellness clinic visit. 
Other factors than lifestyle changes in addition to the screening bias mentioned 
could have caused the observed improvement.  One example is that employees 
could have incorporated prescriptions from their private physicians as a way to 
lower their glucose or lipid levels.  Other possible explanations include 
differences in risk status at the outset between the two groups and insufficient 
sample size to provide valid results 
 
Initial differences between groups:  The significant result observed for triglycerides 
could have been due to initial mean biomarker differences between the exposed 
and unexposed groups. Table A1 shows the mean baseline values in the 
exposed and unexposed groups for the four biomarkers.  For triglycerides data 
there was a large initial abnormality in the exposed versus the unexposed group 
(257 mg/dL vs. 217 mg/dL).  The mean difference in this value between exposed 
and unexposed groups was 26% of the normal cut-off value used of 149, 
compared with 15% for the larger mean initial abnormal value in the exposed 
versus the unexposed group for glucose (129 mg/dL vs. 114 mg/dL). For HDL 
and LDL the initial abnormal value difference between groups was only between 
2% and 3% of the cutoff (Table A1).  This difference between exposed and 
unexposed groups in initial biomarker elevation above normal is also illustrated in 
Figures A9 – A12 in the Appendix. 
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Sample sizes:  The observed significant result only for triglycerides could have 
been due to sample size differences along with the initial value differences, for 
the four biomarkers studied.   Because this was a retrospective study using data 
that were already gathered and from a voluntary participant pool, sample sizes 
obtained for analysis for the four biomarkers in the two groups were not flexible.   
 
The sample size necessary to show particular effect sizes in changes of the four 
biomarkers at a study power of 80% was estimated.  These estimates are given 
in Table 7.   The table also shows effect sizes used in other published studies 
(cited by first author’s name), as well as the present study’s sample sizes.  
Estimated sample sizes in the table were calculated using the online sample size 
calculator from Open Epi (Dean, Sullivan, & Soe, 2011).  Estimates were 
calculated for two effect sizes, for trial purposes.  The effect sizes were arrived at 
by using either:  
 
1. 0.4 of the standard deviation, using the larger standard deviation of the 
exposed and unexposed groups, or 
2. 10% of the lowest abnormal, which was, for glucose 100mg/dL, for 
triglycerides 150mg/dL, for HDL 40 mg/dL and for LDL 120 mg/dL 
 
The calculation in both cases relates the chosen effect size to the variability, or 
standard deviation of the obtained measures.  To avoid the need for large 
sample sizes from using unbalanced groups in the calculation, the equation for 
equal group sizes was used.  By convention, power = .80 and alpha two-tailed of 
.05 were used.   
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Table 7:  Sample size calculation examples 
Sample sizes from 
selected studies 
Biomarker 
screened 
Effect Size mg/dL  Std Dev 
Exp/Unexp 
Estimated 
Sample Size 
from Open 
Epi 
Karlehagen 2003 
    Exposed = 95 
    Unexposed = 74  
Total 
Cholesterol 
10 25 99 per group 
Racette 2009  Glucose 4 Not reported N/A 
    Exposed = 68 
    Unexposed =55 
Triglycerides 5 Not reported N/A 
HDL Chol 1 Not reported N/A 
 LDL Chol 3 Not reported N/A 
     
This study 
 
Exposed/Unexposed 
  1. Estimate: 0.4 X 
SD or 
 2. Estimate: 10% of 
lowest abnormal 
(3. Actual, i.e. 
observed  mean 
difference between 
exposed and 
unexposed) 
  
20/59 Glucose 20 v 10 (18) 50/24 61 v 242 each 
33/45 Triglycerides 39 v 15 (39) 98/91 93 v 624 each 
20/27 HDL 4 v 2 (0.36) 5/6 30 v 120 each 
50/78 LDL 13 v 12 (8.2) 32/22  71 v  83 each 
 
As the table shows, the samples obtained in the present study were smaller than 
what would be required, based on the estimates, to obtain sufficient power for 
statistically significant results.  Despite this, it is not surprising that triglycerides 
showed a significant improvement whereas glucose and HDL did not, given that 
the sample sizes were lower, less than 30 for the exposed, for these two 
biomarkers.  LDL had the largest sample size and a significant intra-subject 
change (Table 4), so the improvement observed in the exposed group could 
have been expected to be significant. However for LDL the mean initial abnormal 
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value was only slightly larger for the exposed group than the unexposed and the 
difference between the two groups was just 3% of normal (Table A1).  
 
A larger effect size was observed for triglycerides than for LDL in this study 
(Table 7).  This large effect size was maintained even after adjusting for the high 
variability of triglycerides with a standard deviation of 98 in the exposed group, 
and reflects the greater abnormality at baseline in the exposed group for 
triglycerides previously discussed (Figure A6).  Thus the combination of sufficient 
sample size and larger demonstrable effect size for this biomarker, could account 
for the significance of the improvement observed for triglycerides but not for LDL 
or the other biomarkers. 
  
Table 7 also shows that future studies using a similar method will require 
relatively modest increases in sample sizes to compensate for the effect size 
differences.  For example, for LDL cholesterol, given the standard deviation of 32 
for the exposed sample in this study, the exposed group would have to be 
increased from 50 to 71 to show a significant benefit of the wellness clinic.  
Increasing the sample sizes in future assessments will likely also decrease the 
variability in biomarker levels that was seen in the present study which would 
have an added effect toward enhancing the validity of findings in this population.  
 
Effect of covariates:   Results for adjustments (Table 6), showed both age and 
gender have an impact on outcomes.  These data indicate gender has a greater 
masking effect on glucose improvement, and age is more likely to affect 
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triglycerides, also as a confounder.  However, significance for these results is 
weak.  The trends require confirmation with studies that have larger sample sizes 
for greater study power. 
 
Benefits and limitations of the study 
This is the first study that looks at an intervention conducted by resident 
physicians entirely within a VA medical center.  It is also the first study in this 
setting that looks at four different specific biomarkers for cardiovascular disease 
employing a control group and adjusting by covariate analysis for age and 
gender.  The positive results from this study come at a time when preventive 
health care is increasingly urgent.  Clinics such as the JAHVA employee 
wellness program provide training to residents in preventive medicine.  Such 
training will become indispensable in today’s health care arena, and as it does 
the resident clinic described in this study has potential to serve as a model 
intervention.   
The medical centers of the VA already contribute greatly to training residents in 
diverse medical disciplines.  The VA is important in continually improving medical 
training through innovative practices.  Two examples are MOVE!, a program 
addressing the specific occupational cohort of former service personnel, and the 
VA’s system-wide diffusion of electronic medical records as the way forward for 
patient data management.  The VA’s electronic records system allows for 
seamless access to a wide variety of records in a way that greatly facilitates 
individual care as well as population studies.  Thus the improvement obtained 
through the VA’s dedication to innovation is evident. 
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In the present study an electronic records based system is used to evaluate a 
worksite health promotion program and to recommend improvements in its 
design.  Such use of electronic records systems is another model practice for 
residents in preventive medicine.  As mentioned the VA provides leadership in 
this and other areas of medical education, and partnerships between the VA and 
university training centers are likely to continue to grow..  Benefits to residents 
and VA employees have been described, both  from the performance of this 
study and its results.  This study thus provides input to help shape the increasing 
role of VA medical centers in medical education. 
 
This investigation employed a retrospective study design to evaluate a health 
promotion program.  The evaluation method  has several strengths and 
limitations.  Strengths of this study method are high replicability due to the 
standard nature of parameters established by a large volume of pre-existing 
research.  Another strength is the use of password-protected electronic records.  
These are more detailed, more easily handled, and more private than paper 
records and thus greatly facilitate data collection.  Improved uptake of wellness 
education is likely to occur in the future as worksites constantly seek to enhance 
public image and competitiveness.  Outcomes data from wellness programs is 
therefore likely to grow significantly in the future along with a need for methods 
such as this one to assess wellness programs.  The use of computerized records 
should facilitate continual improvements in these evaluation methods.  The use 
of a control group to provide a rigorous comparison method was another strength 
of this study. 
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Weaknesses of this method include the use of a convenience sample, which 
resulted in sample sizes too small to achieve statistical significance for some of 
the biomarkers.  As mentioned, this limitation is likely to improve in future 
replications of this study due to the likelihood of increased numbers of workers 
seeking wellness counseling.  Another limitation is that occupational category 
was not included in the demographic descriptors.  This was due to confidentiality 
considerations, to prevent identifiable information that could conflict with 
employees’ rights to participate anonymously in the lipid screening program.  
Finally, in this study initial health indicators were limited to age, gender, and 
baseline biomarker values while outcomes were limited to repeated biomarker 
levels.   Other indicators of initial risk such as body mass index (BMI), high blood 
pressure, or smoking status were thereby excluded, as were outcomes indicative 
of reduced risk through lifestyle change such as lowering BMI, lowering blood 
pressure without medications and quitting smoking. Program changes are 
suggested to address this limitation when using this method in future evaluations.    
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V.   CONCLUSIONS AND FUTURE DIRECTIONS 
 
The findings of improved biomarker levels and attendant cardiovascular risk in 
employees who participate in wellness clinic compared with controls are 
encouraging.  They provide impetus for continued tracking of results for both 
participants in wellness clinic and non-participants.  Such tracking can be 
accomplished more easily in future years given the templates for data collection 
and the flow process for analysis established for this study, although 
modifications will be necessary for future data.  There is a need for increased 
sample sizes to further clarify results from this study.  Concomitantly, there is 
capacity to increase participation levels in the JAHVA lipid screening program 
from the current levels of less than 10% of the estimated 5000 employees at the 
medical center.  (353/5000 = 7%).   
 
This study showed improvement in serum biomarkers for cardiovascular risk in 
an intervention group compared with control subjects.    Improvement could have 
been due to other factors than lifestyle changes.  For example, employees could 
have incorporated prescriptions from their private physicians as a way to lower 
their cholesterol.  This possibility was not controlled for, a limitation due to the 
study’s exclusive reliance on retrospective analysis of records from participants 
who voluntarily presented for screening.  Employees’ opting out of repeat annual 
screening and follow-up wellness visits limits program evaluators’ ability to 
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survey the employees’ behavior over time to find out how they implemented 
lifestyle changes and which ones were successful.  This limitation can be 
addressed in future studies by wellness program measures to sustain the 
participants’ repeated involvement over time and by including regular health risk 
assessments as part of the yearly lipid screening. 
 
In conclusion, this study suggests the following 5 potential refinements to the 
JAHVA employee wellness lipid screening program 
1. Target employee participation increases to levels that are either 
suggested by sample size calculations above, or that are in alignment with 
other VA regional and national programs 
2. Increase employee participation in annual lipid screening by 
a. Increasing employee awareness of the lipid screening  and 
wellness clinic  benefits as central to their optimal use of health 
promotion activities and resources generally available at the 
JAHVA  facility, and 
b. Providing rewards for participating such as lunch bags, 
pedometers, gym bags and discounts for gym clothes 
3. Require baseline health risk assessments prior to lipid screening ( so as to 
amplify data available for evaluation of health promotion at JAHVA) and, 
4. Continuously analyze incoming data retrospectively  for program 
evaluation purposes. 
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Requiring a preliminary health risk assessment or HRA for all who elect to 
undergo glucose and lipid screening may deter some from participating.  There 
will be extra time required to complete the HRA which is a change from current 
practices.  Resistance to this change may exist for various reasons such as 
employee unwillingness to schedule time to complete the HRA. 
Making the HRA a requirement will likely also increase costs to the health 
promotion program for implementing and managing the collection of additional 
data.  It may then also be necessary to pass on this extra cost to participants in 
contrast to the current program charge, a nominal $3 fee. 
 
 Changing the current practice to one of mandating an HRA may thus seem 
counterproductive.   However, rationing a product can enhance its desirability 
and thereby increase demand for it.  In this case the rationing mechanisms of 
time and price costs are actually investments intended to improve program 
quality.  Such a change will therefore not necessarily cause decreased 
participation but could, on the contrary, enhance employee participation by 
raising the profile of the lipid screening program, and by highlighting a 
convenient, accessible resource that employees may increasingly consider to be 
a worthwhile investment. 
 
Age and gender are both elements of cardiovascular risk, with risk being lower 
for younger age and female gender (seen in Figures A1-A3).   Covariate analysis 
of our data showed an impact from age and gender indicating that difficulty in 
improving triglyceride levels may be related to age, and difficulty in improving 
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glucose levels may be related to age and gender.  However, other confounders 
were present in this study and could also have affected outcomes.  Age and 
gender were the only health risk parameters available for both exposed and 
unexposed groups due to the lack of a health risk assessment in subjects who 
underwent only screening.  With the recommendation to obtain a health risk 
assessment, additional covariates will be available, such as body mass index 
(BMI), family history, and smoking status.  Analyzing these will better 
characterize the specific population at this worksite and enhance knowledge of 
the specific contribution of above-named health indicators in future assessments 
of wellness program outcomes.  
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APPENDIX:  ADDITIONAL FIGURES & TABLE 
 
                                           
Cardiovascular Risk 
Determination –
Framingham Risk 
Assessment Tool
NATIONAL CHOLESTEROL EDUCATION PROGRAM
Third Report of the Expert Panel on
Detection, Evaluation and Treatment of High Blood Cholesterol in 
Adults ( Adult Treatment Panel III) 
JAMA  (2001): The Journal of the American 
Medical Association, 285(19), 2486-2497. 
http://hp2010.nhlbihin.net/atpiii/calculator.asp?usertype=prof
o Age
o Gender
o Total Cholesterol
o HDL  Cholesterol
o Smoking status
o Systolic Blood Pressure
Calculate  10-Year Risk
 
    Figure A1.  Framingham Risk Calculator  
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APPENDIX (Continued) 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
          Figure A2.  NCEP ATP – III algorithm for determining target LDL level  
 
Cardiovascular Risk Determination –  
NCEP ATP - III Approach 
 
Major Risk Factors (Exclusive of LDL cholesterol) That Modify LDL Goals 
• Cigarette smoking 
• Hypertension, with BP >=140/90 mm Hg or on antihypertensive 
medication 
• Low HDL cholesterol, < 40 mg/dL  
• Family history of premature coronary heart disease, in male first degree 
relative <55 or in female first degree relative at <65 years of age 
• Age of 45 or older in men, 55 or older in women. 
• Diabetes is regarded as equivalent to coronary heart disease. 
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APPENDIX (Continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
        Figure A3.  NCEP ATP – III criteria for diagnosing metabolic syndrome 
 
Cardiovascular Risk Determination –  
Metabolic Syndrome 
 
Metabolic Syndrome: >3/5.   
(Values for Abdominal obesity and HDL are for women/men) 
 
• Abdominal obesity >35/40 inches 
• Triglycerides > 150 mg/dL  
• HDL cholesterol < 50/40 mg/dL  
• Blood pressure >130/>85 mmHg 
• Fasting glucose >110mg/dL  
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Weight Control:
Switch from regular to diet soda
Walk with a friend  or use a pedometer for 
motivation
Bring your own lunch to work to get portion 
control
Raise your HDL cholesterol by
Quitting smoking
Eating walnuts, salmon and blueberries
Getting regular exercise
 
 
        Figure A4.  Example of Wellness ‘prescription’
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             Figure A5.  Age distribution of exposed group 
 
             
             Figure A6.  Age distribution of non-exposed group 
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             Figure A7.  Gender of exposed group 
          
               
              Figure A8  Gender of non-exposed group 
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APPENDIX (Continued) 
Table A1:  Mean difference for paired measurements 
 
 
N 
 
Mean baseline 
value (mg/dL) 
 
Mg/dL 
decrease (or 
increase) 
 
% Decrease 
(or increase) 
 
P-value for paired 
measurements 
Glucose      
Exposed 20 129.3 19.7 15.2 .092868 
Unexposed 59 114.4 1.7 1.4 .603641 
Triglycerides      
Exposed 33 256.6 44.5     17.3      * .013607 
Unexposed 45 217.7 5.1 2.3 .713276 
HDL cholesterol        
Exposed 20 34.5 (2.8) (8.1)     * .010619 
Unexposed 27 35.7 (3.1) (8.7)     * .006884 
LDL cholesterol      
Exposed 50 146.7 17.6 12.0     * .000336 
Unexposed 78 143.6 9.4   6.5      * .000371 
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                  Figure A9-1.  Initial glucose level in exposed                      Figure A9-2. Initial glucose level in unexposed  
                                 
                  Figure A10-1.  Initial triglyceride level in exposed                 Figure A10-2.  Initial triglyceride level in unexposed 
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                Figure A11-1.   Initial HDL level in exposed                               Figure A11-2.  Initial HDL level in unexposed 
                         
      Figure A12-1.  Initial LDL level in exposed                               Figure A12-2.  Initial LDL level in unexposed 
